Skip to content

Observation of occurrence, influencing factors and prognosis of fatigue related to neurological diseases

Observation of occurrence, influencing factors and prognosis of fatigue related to neurological diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096619
Enrollment
Unknown
Registered
2025-01-26
Start date
2025-02-10
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, spinal cord injury, Parkinson's disease and other neurological diseases

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age: >=18 years old; 2. Stroke: The diagnosis of ischemic stroke and hemorrhagic stroke is based on relevant diagnostic criteria 3 in Chinese Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke 2018 and Chinese Guidelines for the Diagnosis and Treatment of Cerebral Hemorrhage (2019), respectively. Spinal cord injury: injury due to trauma (including cauda equina injury) or non-traumatic spinal cord injury (vasogenic infection or tumor), diagnosed according to the 2011 Neurological grading criteria 4. Meets the diagnostic criterion 5 for MS in the 2017 revised McDonald Standard. Meet the diagnostic criteria for Parkinson's disease in 2016 edition of China 6. Other neurological diseases, such as brain trauma, brain tumor, etc., meet the corresponding diagnostic criteria 7. Vital signs stable, conscious, informed and consenting to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Those with severe auditory comprehension or cognitive impairment that affects their understanding of the research process or provides accurate feedback; 2. Patients with other major diseases such as malignant tumors, severe mental illness, bleeding disorders, endocrine diseases or systemic immune system diseases; 3. Concomitant other serious physical diseases that affect fatigue: such as severe heart disease, liver disease, chronic obstructive pulmonary disease or other major diseases that may affect the individual's fatigue; 4. Those who have metal objects such as pacemakers, stents, and dentures installed in the body 5. Patients with a history of drug abuse, hormone therapy, or alcohol abuse within the past 6 months; 6. Pregnant or women preparing for pregnancy; 7. Participants who are unwilling or unable to sign informed consent.

Design outcomes

Primary

MeasureTime frame
Fatigue;Safety evaluation;

Secondary

MeasureTime frame
Cognitive Function;Sleeping;Emotion;Motor function;Activity of daily living;Heart rate variation;Functional near infrared spectroscopy;Motor evoked potential;Quality of living;

Countries

China

Contacts

Public ContactYang Yun

The First Affiliated Hospital of Nanjing Medical University

yangyun2066@163.com+86 183 5197 2181

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026